Evidence map›Paper›PMID 10323879›Full record

ArticleGut1999

Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.

G Nardone, S Staibano, A Rocco, E Mezza, F P D'armiento, L Insabato, A Coppola, G Salvatore, A Lucariello, N Figura and 2 more

Erratum issuedOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Gut, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 129 citations in OpenAlex.

  1. Trial
  2. Change of Expression of Ki 67, P53, and Cyclin D1 Immunoreactivity afterMiddle East journal of digestive diseases · 2025
    Article
  3. Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  4. Overview ofDiseases (Basel, Switzerland) · 2021
    Review
  5. Review
  6. Review
  7. Article
  8. Association ofWorld journal of oncology · 2019
    Article
  9. Article
  10. Review
  11. Eradication ofClinical medicine insights. Gastroenterology · 2016
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. The role of oncogenes in gastrointestinal cancer.Gastrointestinal cancer research : GCR · 2010
    Article
  19. MYC and gastric adenocarcinoma carcinogenesis.World journal of gastroenterology · 2008
    Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

G NardoneDipartimento di Patologia Sistematica, Cattedra di Gastroenterologia, Università degli Studi "Federico II", via Pansini 5, 80131 Naples, Italy.
S Staibano
A Rocco
E Mezza
F P D'armiento
L Insabato
A Coppola
G Salvatore
A Lucariello
N Figura
G De Rosa
G Budillon
University of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori, the main cause of chronic gastritis, is a class I gastric carcinogen. Chronic gastritis progresses to cancer through atrophy, metaplasia, and dysplasia. Precancerous phenotypic expression is generally associated with acquired genomic instability.

aimTo evaluate the effect of H pylori infection and its eradication on gastric histology, cell proliferation, DNA status, and oncogene expression. METHODS/SUBJECTS: Morphometric and immunohistochemical techniques were used to examine gastric mucosal biopsy specimens from eight controls, 10 patients with H pylori negative chronic gastritis, 53 with H pylori positive chronic gastritis, and 11 with gastric cancer.

resultsAll patients with chronic gastritis were in a hyperproliferative state related to mucosal inflammation, regardless of H pylori infection. Atrophy was present in three of 10 patients with H pylori negative chronic gastritis and in 26 of 53 with H pylori positive chronic gastritis, associated in 18 with intestinal metaplasia. DNA content was abnormal in only 11 patients with atrophy and H pylori infection; eight of these also had c-Myc expression, associated in six cases with p53 expression. Fifty three patients with H pylori positive chronic gastritis were monitored for 12 months after antibiotic treatment: three dropped out; infection was eradicated in 45, in whom cell proliferation decreased in parallel with the reduction in gastritis activity; atrophy previously detected in 21/45 disappeared in five, regressed from moderate to mild in nine, and remained unchanged in seven; complete metaplasia disappeared in 4/14, and markers of genomic instability disappeared where previously present. In the five patients in whom H pylori persisted, atrophy, metaplasia, dysplasia, and markers of genomic instability remained unchanged.

conclusionsChronic H pylori infection seems to be responsible for genomic instability in a subset of cases of H pylori positive chronic atrophic gastritis; eradication of H pylori infection can reverse inflammation and the related atrophy, metaplasia, and genomic instability.

Indexed as

Helicobacter pyloriAdultAgedAneuploidyAnti-Bacterial AgentsAtrophyCell DivisionChronic DiseaseDNAFemaleFollow-Up StudiesGastric MucosaGastritisGene ExpressionGenes, bcl-2Genes, mycAnti-Bacterial AgentsDNAProliferating Cell Nuclear Antigen

Identifiers

PMID10323879
PMCPMC1727537
OpenAlexW1987822516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.